Thus one cannot exclude the possibility that the macrodomain-containing ARTD9, ARTD8 or ARTD7 may indeed functionally interact with ARTD1 in DLBCL and even block the enzymatic and potential tumor suppressor activity of ARTD1 through their macrodomains. The gene discussed is PARP1; the disease is diffuse large B-cell lymphoma.